Papers
2
Total Citations
63
H-Index
2
About
Dr. Sujith Baliga is a leading surgical oncologist whose research focuses on advancing the treatment of oropharyngeal squamous cell carcinoma (OPSCC), particularly through the use of transoral robotic surgery (TORS). His major contributions center on optimizing surgical outcomes and minimizing the need for toxic multimodality therapy. In his highly cited 2018 study (50 citations), Dr. Baliga demonstrated that TORS can significantly improve survival rates and reduce the use of adjuvant chemotherapy in OPSCC patients, offering a less morbid alternative to traditional treatments. His 2020 work (13 citations) further refines this approach by identifying key clinical and socioeconomic predictors of adjuvant therapy following TORS, providing crucial guidance for patient selection and treatment planning. This research helps ensure that patients receive the most effective, least burdensome care possible. Dr. Baliga’s work is instrumental in shaping modern, minimally invasive strategies for head and neck cancer, directly impacting clinical decision-making and improving patient quality of life.
Research Focus
Key Achievements
Top Papers
- 1
- 2